Kymera Therapeutics

Kymera Therapeutics to Present at Morgan Stanley 18th Annual Global Healthcare Conference

WATERTOWN, Mass., Sept. 14, 2020 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein